Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X): Funding calls 2026 – EOI

The CARB-X 2026 funding round features four distinct themes:
– Direct-acting therapeutics for infections caused by Gram-negative bacteria
– CARB-X Novel Chemistry for AMR Challenge – target-based therapeutics
– Non-vaccine approaches to prevent neonatal sepsis
– Diagnostics for neonatal sepsis
Funding: varies
https://carb-x.org/apply/funding-themes/
https://carb-x.org/apply/application-process/